QualityStocksNewsBreak – Aegis Capital Reiterates “Buy” Rating on CytoSorbents Corp. (NASDAQ: CTSO)

Following CytoSorbents Corp.’s (NASDAQ: CTSO) appointment of a new chief medical officer (CMO), Aegis Capital reiterated its ‘Buy’ rating and price target of $9 on shares of the company’s stock. The company recently named Dr. Eric G. Mortensen, M.D., Ph.D., as its new CMO, starting full-time tomorrow. Dr. Mortensen holds an M.D. from Harvard University and Massachusetts Institute of Technology Division of Health Sciences and Technology, and a Ph.D. in biophysics from the Harvard Graduate School of Arts and Sciences. Former CMO Dr. Robert H. Bartlett, M.D. will retire after nine years with the company, but will remain as a consultant and as co-chair of Cardiac Surgery Advisory Board through the REFRESH 2 cardiac surgery trial.

For more information, visit www.cytosorbents.com.

About CytoSorbents Corporation (NASDAQ: CTSO)

CytoSorbents Corporation is engaged in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 43 countries around the world, as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury and pancreatitis, as well as in cancer immunotherapy. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators, such as cytokines and free hemoglobin, which can lead to post-operative complications, including multiple organ failure. CytoSorbents has completed its REFRESH (REduction in FREe Hemoglobin) 1 trial – a multi-center, randomized controlled study that has demonstrated the safety and efficacy of free hemoglobin reduction with intra-operative CytoSorb® use in a heart-lung machine during complex cardiac surgery. In 2017, the company plans to initiate a pivotal REFRESH 2 trial intended to support U.S. FDA approval. CytoSorb® has been used safely in more than 23,000 human treatments to date. CytoSorbents’ purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding in excess of $18 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL, HemoDefend™, VetResQ™, ContrastSorb, DrugSorb, and others.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreak – MEI Pharma, Inc. (NASDAQ: MEIP) Exceeds Pre-Specified Response Rate Study of ME-401 in CLL and Follicular Lymphoma

Shares of MEI Pharma (NASDAQ: MEIP) are higher in mid-day trade on news that an independent Safety Review Committee has completed its pre-specified review of the first cohort of six evaluable patients in a phase Ib study of the company’s potent and selective oral PI3K delta inhibitor, ME-401, in relapsed/refractory chronic lymphocytic leukemia (CLL) and follicular lymphoma. “PI3K delta inhibitors have demonstrated clear activity in the treatment of CLL and follicular lymphoma, but at the expense of well-defined and substantial toxicities. We believe this provides an opportunity for a highly differentiated drug that is both effective and safe. Now we look forward to demonstrating the therapeutic index of ME-401 across multiple dose cohorts and presenting detailed results later this year,” MEI Pharma president and CEO Daniel P. Gold, Ph.D. stated in the news release. The company said it intends to submit full data from the open-label, dose-escalation study for presentation at an upcoming scientific meeting.

To view the full press release, visit: http://nnw.fm/QwK83

About MEI Pharma

MEI Pharma, Inc. (NASDAQ: MEIP) is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The company’s portfolio of drug candidates includes Pracinostat, an oral HDAC inhibitor that is partnered with Helsinn Healthcare, SA. Pracinostat has been granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for use in combination with azacitidine for the treatment of patients with newly diagnosed AML who are unfit for intensive chemotherapy. Pracinostat is also being developed in combination with azacitidine for the treatment of patients with high and very high-risk myelodysplastic syndrome. MEI Pharma’s clinical development pipeline also includes ME-401, a highly differentiated oral PI3K delta inhibitor currently in a phase Ib study in patients with relapsed/refractory CLL or follicular lymphoma. The company is also developing ME-344, a novel mitochondrial inhibitor currently in an investigator-sponsored study in combination with bevacizumab for the treatment of HER2-negative breast cancer. Pracinostat, ME-401 and ME-344 are investigational agents and are not approved for use in the U.S. For more information, please visit www.meipharma.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreak – EMA Committee for Orphan Medicinal Products Recommends Designation for Catalyst Biosciences, Inc.’s (NASDAQ: CBIO) Factor IX

Shares of Catalyst Biosciences (NASDAQ: CBIO) are 15% higher this morning on news that a positive opinion recommending orphan medicinal product designation has been issued by the European Medicines Agency Committee (EMA) for Orphan Medicinal Products (COMP) regarding Catalyst’s CB 2679d for the treatment of hemophilia B. The clinical-stage biopharmaceutical company’s highly potent next-generation coagulation Factor IX variant demonstrated potential to normalize human Factor IX levels with a daily subcutaneous injection in preclinical studies. Currently approved therapies rely on numerous intravenous infusions. “Obtaining orphan drug designation is an important part of our regulatory approval strategy for CB 2679d, and the receipt of the positive COMP opinion puts us one step closer to this goal,” Catalyst president and CEO Nassim Usman, Ph.D. stated in the news release.

To view the full press release, visit: http://nnw.fm/1iAwB

About Catalyst Biosciences, Inc.

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia. For more information, visit www.catalystbiosciences.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

SinglePoint, Inc. (SING) Provides Payment Infrastructure to Marijuana Retailers as Cannabis Sales Hit $1B in Colorado

Now that 29 states and the District of Columbia have legalized medical or recreational marijuana, or are on the way to doing so, the buzz in the industry is being supported with hard data. A new comprehensive report from Marijuana Business Daily (MBD) is replete with figures, charts, projections and analyses that support the upbeat ‘animal spirits’ in the industry. Titled the Marijuana Business Factbook 2017 (http://nnw.fm/L2Tnt), the paper projects that revenues from medical and recreational marijuana products will surpass $5 billion in annual sales for the first time in 2017. However, until federal statute allows, banks are unlikely to handle these “high risk” payments, which opens the door for innovative fintech companies like SinglePoint (OTC: SING) to step in. The company is positioning itself to be a ‘first mover’ in providing payment solutions to the cannabis vertical through its SingleSeed payments subsidiary.

The MBD report, summarizing the responses of more than 800 business owners, executives, entrepreneurs and investors, reveals a more uncertain industry outlook. In the 2016 survey, the hazard of federal intervention ranked as the third-most worrying challenge facing marijuana business owners. This year, that troubling threat is now their primary concern.

However, there is a silver lining as sales of recreational marijuana have been going up. Adult-use sales in Colorado and Washington, which became legal in both states in 2014, exceeded $1.5 billion in 2016. Voters in the two states approved the legalization proposals in November 2012. In 2017, total retail sales of all categories of marijuana are forecast to climb by 30 percent over 2016, ‘hitting $5.1 billion-$6.1 billion,’ according to the MBD report. And in 2017, recreational sales are expected to surpass medical for the first time. Since the banks do not want to facilitate these marijuana-related transactions, that leaves an awful lot of cash on the table.

With its suite of payment options, SinglePoint is poised to take some of that cash off the table. The company is offering innovative ways in which customers and patients can pay for all their marijuana purchases. Its SingleSeed payments subsidiary provides cannabis shops and dispensaries with solutions that closely resemble the typical debit/credit card terminal.

SinglePoint also provides Pay-by-Text technology, which facilitates both promotional outreach and payments. Pay-by-Text offers a swipe-less payment option to customers. The purchaser makes a payment by sending a text message to the payment provider, who clears the transaction with the vendor.

With these technological tools, SinglePoint is taking its ‘no touch’ approach to the cannabis industry a step further.

For more information visit the company’s website at www.SinglePoint.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

ProBility Media Corp. (PBYA) eLearning Programs Offer Training to Re-Skill U.S. Workforce

A prescient report (http://nnw.fm/T19dA) from the Paris-based Organisation for Economic Cooperation and Development (OECD) lays bare the dearth of “basic” and vocational skills in the U.S. Despite a relatively high level of education, the U.S. experiences a weakness in basic skills when compared to other developed countries, according to the report. As a result, the authors of the study recommend making skills training for young adults more accessible, while linking this training to career development. This is exactly what vocational training company ProBility Media Corp. (OTC: PBYA) is doing. With its suite of training and test preparation solutions, the Texas-based educational technology company is out to develop the first full service training and career advancement brand for technical vocations and skilled trades.

ProBility is aiming to disrupt the technical vocations training and certification industry by creating the first full service training and career advancement brand in the technical fields. A major plank in this strategy is the development of online training programs employing virtual reality technology. In the HVAC field, for example, ProBility’s eLearning products under development include a full HVAC technician’s course that simulates the hands-on experience of a lab and physical school. This practical training is supplemented with a handbook produced by ProBility’s publishing division.

Details of the OECD report show the market opportunity America’s skills gap presents for ProBility. As expected, the ability to cultivate the aptitude needed to work at a trade is impeded if basic skills are lacking. Some math proficiency, for example, is required in most vocations, leading, generally, to a greater awareness and emphasis on developing numerate skills. However, literacy is just as important. Language is an important medium not just for learning but also for reasoning. Most of the time, our conscious cogitation is in verbal terms as we “talk” ourselves through a series of actions or a problem solving sequence. Having a command of grammar and syntax also aids in interpreting and assessing information. This may be why the U.S. also scored low on a related skill: problem solving in technology-rich environments.

More so than in other OECD countries, “socio-economic economic background has a stronger influence on adult basic skills.” However, basic skills are linked not only to employment outcomes, but also to personal and social well-being, the report goes on to point out. The odds of having low levels of health are four times higher for low-skilled U.S. adults than for those with the highest skills, a ratio that is twice the OECD cross-country average.

Other findings of the study point to opportunities for ProBility to deploy its extensive array of online training programs. Most (63%) low-skilled adults in the U.S. are employed, a higher proportion than in other countries. Consequently, they can be targeted through workforce development and evening adult programs. In addition, “participation rates in adult education and training are higher in the U.S. than in most countries at all skill levels, although, as elsewhere, low-skilled adults are less likely to participate.”

On par with these findings, ProBility is continually expanding the range of its training and testing services, through organic growth and by acquisitions, as it executes its strategy of defragmenting the vocational training industry. The company is positioning itself as a one-stop-shop for individuals, small- and medium-size businesses (SMEs), and large enterprise customers in the market for high-quality training services and materials to promote career advancement. ProBility is now, also, one of the largest wholesale supplier of electrical codes in the U.S. and provides exam preparation and certification in 22 states.

For more information, visit the company’s website at www.ProBilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

UGE International Ltd. (UGEIF) Revenues Rocket 903% Higher as Solar Power Orders Surge

There are clear skies over the NYC headquarters of UGE International (OTCQB: UGEIF) (TSXV: UGE) as the energy solutions company continues to build its business organically and through acquisitions. UGE recently announced its first-quarter 2017 financial results, boasting record revenues of $5.5 million, up 903% over the prior year period. Now, the global provider of solar energy services is on track to take that top line even higher as its order book swells.

The solar power industry is driven by renewable portfolio standard (RPS) targets, state and federal tax credits, grants, and favorable public support for ‘green’ energy. A renewable portfolio standard (RPS), or renewable electricity standard, is a regulatory mandate to increase production of energy from renewable sources such as wind, solar, biomass and other alternatives to fossil and nuclear electric generation. The industry has experienced phenomenal growth over the past five years, achieving annual growth rate of approximately 76 percent from 2011 through 2016. A new report from GTM Research and SEIA (http://nnw.fm/bnLW5) indicates that rate could be trending even higher, revealing that the U.S. solar power market grew by 95 percent in 2016.

UGE is on the frontline of this industry as it powers its way into photovoltaic energy solutions; its recent financial results reflect that position. In the first quarter of 2017, UGE reported triple-digit growth in revenues (as noted above) and lowered its net loss to $0.4 million, compared to $1.7 million reported in the first quarter of 2016, marking the smallest loss in the last three years and bringing the company closer to profitability.

At March 31, 2017, the company also reported that its order backlog reached $31.6 million, of which $20.5 million were “confirmed” projects and $11.1 million of which were “contracted” projects.
“Our first quarter results further illustrate the progress we are making as a company to grow profitably in the commercial solar sector,” UGE CEO Nick Blitterswyk stated in the news release. “Our team continues to focus on growing and executing on our backlog, as our expectations for the future continue to grow as well.”

UGE provides services at all stages of the solar photovoltaic (PV) project lifecycle, including consulting and project management, engineering and design, turnkey construction, and development. The company has been engaged in a number of high-profile projects in the Northeast United States, Canada, Panama and the Philippines.

It was involved in the 84-panel installation that will provide 25.2 kW DC to the San Francisco campus of file-hosting company, Dropbox, and also undertook the utility scale ground mount installation at Sandringham and Woodville Solar Farms for Invenergy Clean Power of Ontario that will generate 25 MW (megawatts) of power. With a resume of over 130 commercial and industrial projects, UGE has already participated in installations with a capacity of over 280 MW.

With such a sunny prognosis, UGE’s share price has been on the rise, increasing by about 30 percent over the 12 months.

For more information, visit the company’s website at www.ugei.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

SinglePoint, Inc. (SING) Targeting Market Domination

Two significant acquisitions in the last three months is more than a pattern. It’s an out-right destination. This recent audio interview http://nnw.fm/8w4N9 with Greg Lambrecht, CEO of SinglePoint (OTC: SING), discusses some of the synergies and the immense opportunities that come with the company’s recent acquisition of 90% of Discount Indoor Garden Supply (“DIGS”) (www.DIGSHydro.com).

These strategic accretive acquisitions position SinglePoint to become a dominant player in the California cannabis market while never actually touching the plant.

In March, SinglePoint announced its acquisition of Orange County-based Convectium, which provides branding, packaging, equipment and a proprietary oil filling system ready to rock the cannabis market.
Earlier this month, SinglePoint added southern California-based DIGS to its portfolio (http://nnw.fm/oh7ZW), which brings immediate revenues to SinglePoint and positions the company as a leader in online products, retail stores, cannabis consulting and equipment throughout California.

Many cannabis-related businesses turn to DIGS Hydro’s online store and retail locations for anything and everything needed to cultivate cannabis products, except the seed and plant itself. The owner of DIGS, Carey Haas, has 25 years of experience in the California cannabis markets and brings his knowledge, experience and vast contacts with him to the SinglePoint family of companies.

As a specialized holding company, SinglePoint is building strong relationships as well uncommon companies in its quest to become the dominant force supplying products and services to the California cannabis industry.

The company is rapidly expanding its portfolio in the cannabis markets with strategic accretive acquisitions that profit from servicing the cannabis industry. There’s little doubt the marijuana market in the United States is poised for further explosive upside growth. SinglePoint understands its destination and has taken another huge step toward dominating markets and reaping the attendant rewards.

For more information visit the company’s website at www.SinglePoint.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

QualityStocksNewsBreaks – Player’s Network, Inc. (PNTV): New Medical Marijuana Licenses Enable the Start of Cultivation and Production Operations

Player’s Network (OTCQB: PNTV) today achieved a corporate milestone as it received its medical marijuana licenses that permit the company to commence operations in its 27,000-square-foot facility in North Las Vegas. The company’s plans to become fully operational include activating the core processes necessary to commence cultivation and production operations. Green Leaf Holdings, the company’s subsidiary, is set to begin planting this week under its Cultivation License. “This has been a long journey through the mountains of paperwork and regulatory requirements to become fully compliant. Now we can finally put our plan into place and focus on developing amazing brands within the MMJ industry. Our facility looks amazing and we’re proud of the hard work that has gotten us to this point. I believe when we are fully built out that it will be one of the leading facilities in the world. We couldn’t have done this without the support of our shareholders, so a big thanks to everyone who believed in us,” CEO Mark Bradley stated in the news release.

To view the full press release, visit: http://nnw.fm/8AbNW

About Player’s Network, Inc. (PNTV)

Player’s Network is a diversified company operating in media and cannabis markets. PNTV owns approximately 85% of Green Leaf Farms Holdings, LLC (Green Leaf Farms), which holds cultivation and production license(s) awarded by the state of Nevada. The cultivation license enables Green Leaf Farms to grow marijuana and the production license enables them to create extracts which are used for cartridges, oils and edibles. WeedTV.com is developing the ultimate resource for the marijuana lifestyle within our media operations. For more information please visit www.PlayersNetwork.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Reopened Patent Case Sends ParkerVision, Inc. (NASDAQ: PRKR) Shares Higher

ParkerVision (NASDAQ: PRKR) shares are up 9% in mid-day trade after the radio-frequency technologies company said its request to lift the stay and reopen its patent infringement case against Apple (NASDAQ: AAPL), LG and Qualcomm (NASDAQ: QCOM) was granted by the Middle District of Florida. Additionally, the court ordered the parties to conduct a case management conference within 30 days and subsequently file a case management report within the 14 days following the conference. The company filed its request to reopen the case on May 4 after the International Trade Commission’s ruling to approve the company’s motion to terminate its parallel ITC investigation against these same defendants.

To view the full press release, visit: http://nnw.fm/G8UHd

About ParkerVision, Inc.

ParkerVision, Inc. designs, develops and markets its radio-frequency (RF) technologies and products that enable advanced wireless solutions for current and next generation communications networks. Protected by a highly-regarded, worldwide patent portfolio, the company’s solutions for wireless transfer of RF waveforms address the needs of a broad range of wirelessly connected devices for high levels of RF performance coupled with best-in-class power consumption. For more information please visit www.parkervision.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Quest Management, Inc. (QSMG) Shares Skyrocket on Plans to Acquire Sanavida, Enter Telemedicine Market

Shares of Quest Management (OTC: QSMG) are up 84% mid-morning on news the company is negotiating to acquire Sanavida, which will provide Quest an entry point into the telemedicine market. Sanavida is a solution designed to provide uninsured individuals discounts to certain health care providers. The platform is available in both English and Spanish. A monthly subscription to Sanavida includes online consultation by a physician with no co-pay, discounted medical visits, prescriptions, diabetic supplies, counseling, and more.

To view the full press release, visit: http://nnw.fm/Hk02g

About Quest Management, Inc.

Quest Management, Inc. provides an environment where its group of innovators, operators, employees and investors participate with greater levels of success, efficiency, and satisfaction. The company welcomes all of the unique and valuable characteristics that build best practices. The core tenets of the company’s success are technology, marketing, and sales expertise; all of which enable it to leverage those items within business units to achieve exceptional results. The company has majority and minority stakes in diversified businesses with real demand for their products and services, and is focused on the markets and opportunities it believes will best create value for its shareholders. For more information, visit www.questmanagementinc.net.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com, Inc. (CIIX) Debuts “OptHemp” Premium Line and Readies its First U.S. Retail Store

ChineseInvestors.com’s (OTCQB: CIIX) first retail store is expected to open in June in San Gabriel, California. It will be among the first stores to sell “OptHemp,” a premium health product line launched by CIIX’s wholly owned subsidiary chinesehempoil.com, Inc. The “OptHemp” line will include OptHemp Ultra Premium Hemp Oil, the company’s first private label product.

CIIX offers educational tools and consulting services for Chinese investors. Recently, it has been pursuing its niche in the expanding cannabis (CBD) market. The company’s goal is to become a leading Chinese publicly traded company in the nutritional industry. CIIX’s retail store in California will primarily sell hemp oil-based products, which it will market via a new website, mobile application, and online distribution program to penetrate the rapidly growing hemp-based CBD market.

“I am very pleased to announce the launch of our first premium OptHemp product,” Warren Wang, founder and CEO of CIIX, stated in a recent news release. “Hemp oil is believed to have positive balancing effects on the mind and body of persons using them.”

The formula for OptHemp has been optimized to manage inflammation and pain relief. The OptHemp premium line is GMO-free, reinforcing the product’s purity to users. It is grown in organic farms in Colorado using a CO2 extraction technology.

“We believe that the desire for better quality of life in the Chinese community, coupled with the fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Wang said. “CIIX is confident that its OptHemp product line will lay a solid foundation for the Company’s entrance into the legal hemp industry and the alternative health sector.”

In the future, CIIX will focus on the distribution and R&D into the CBD market. Its products can be used for patients with epilepsy, Alzheimer’s disease, and cirrhosis of the liver. In China, use of marijuana is forbidden, though hemp-based CBDs are legal, creating a target market of approximately 2 billion consumers.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) to Step Up Exploration Efforts following Chinese Production Cuts

Zinc prices soared over the last few days after top consumer China increased imports of the metal in wake of the country’s halting production as part of an environmental crackdown on the local steel industry. The Asian nation’s move to curb zinc and nickel production is likely to have a significant impact on global supply, with inventories already under pressure from growing demand and currently at about 342,675 tons (roughly 20 percent lower than last year), according to Reuters (http://dtn.fm/gP0yM). Zinc exploration corporations such as Vancouver-based Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) are already exploring ways to step up efforts to find deposits so as to help meet the global demand for zinc.

Refined zinc imports to China jumped 21 percent year-over-year last month, reaching 47,469 tons (http://dtn.fm/H9mbb). Similarly, shipments of zinc ore and concentrates increased by 44 percent, Reuters said. This led to a significant increase in zinc prices, with the London Metal Exchange benchmark zinc closing up one percent at $2,658 per ton earlier this week – the highest since the beginning of the month.

Nickel prices also soared to $9,395, the highest in three weeks, as a result of growing Chinese imports. The halt in Chinese nickel production is unlikely to have a major impact, since the country accounts for only four percent of global supply. The situation, however, is significantly different when it comes to zinc, as the Asian nation accounted for at least 38 percent of global production before the crackdown. Both nickel and zinc are used in the steel manufacturing process – zinc for galvanized steel and nickel for stainless steel.

It is yet unclear how much of the country’s zinc and nickel production will be affected by the crackdown, but industry sources say the government is shutting down all steel mills that emit excessive pollution, along with zinc and nickel mining operations. Several of these operations might be reopened if they are found in compliance with environmental regulations, the sources added.

China’s move is likely to drive zinc demand even higher. According to the International Lead and Zinc Study Group, demand for the metal is already exceeding supply, and the difference is expected to reach 226,000 tons this year (http://dtn.fm/Lb7BC).

To help meet the rising demand, Canada’s Kootenay Zinc Corp. has already taken steps to expand its exploration program at its Sully property in British Columbia. The property is located near the legendary Sullivan Mine, which was one of the world’s largest reserves of zinc, with an output of over 17 million tons of zinc and lead until it was closed down in 2001. Kootenay’s Sully Project is located 18 miles from Sullivan, and both properties share different environments of the same basin.

For more information, visit the company’s website at www.KootenayZinc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Monaker Group, Inc. (MKGI) Announces Launch of NextTrip Website and Mobile App

Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced the launch of NextTrip, a new travel website and companion mobile app featuring instant alternative lodging rentals (ALRs). The NextTrip mobile app is now available for download on both Android and iOS devices, giving users access to more than 1.2 million instantly-bookable ALR properties, 200,000 hotels, 400 airlines, all major car rental companies and 10,000 tourist activities. “The launch of NextTrip demonstrates how Monaker has solved one of the biggest pain-points in the travel industry — lack of access to instant booking of ALR,” Bill Kerby, CEO of Monaker, stated in the news release. “So, if you book it, you’ve got it. No waiting minutes or hours as you wait to hear back from the property owner. You can now go ahead and book flight, car or tour packages at the same time of your ALR, all on the same site, and without hesitation.” NextTrip is powered by the Monaker Booking Engine (MBE), a cloud-based technology platform that allows for custom integration into virtually any existing booking platform. Monaker aims to leverage this advanced technology to capitalize on the forecast growth of the ALR industry, which is on pace to top $194 billion in 2021, according to Technavio.

To view the full press release, visit http://dtn.fm/jj1Qb

About Monaker

Monaker Group is a technology-driven travel company focused on delivering innovation to alternative lodging rentals (ALR) market. The Monaker Booking Engine (MBE) delivers instant booking of more than 1.2 million vacation rental homes, villas, chalets, apartments, condos and castles. MBE offers travel distributors and agencies an industry-first: a customizable instant booking platform for ALR. Monaker’s NextTrip.com B2C website, also powered by MBE, is the first to offer significant instantly-bookable ALR products along with mainstream travel products and services all on a single site. NextTrip also features rich content, imagery and high-quality video to enhance a traveler’s booking experience and assist in the search, decision and buying process for both individuals and groups. For more information, visit www.monakergroup.com or www.nexttrip.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

India Globalization Capital, Inc. (NYSE: IGC) Taps Dr. Craig Cheifetz as Advisor for Clinical Trials of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has named Craig Cheifetz, M.D., as an advisor to aid the company in its clinical trials in microbiology, immunology, neuroscience, and biotechnology. IGC is engaged in the development of cannabis-based therapies, which treat pain, terminal neurological and oncological diagnosis, PTSD, seizures, and other life altering issues. The company, based in Bethesda, Maryland, has a portfolio of patent filings for its phytocannabinoid-based treatments.

In a news release, Ram Mukunda, CEO of IGC, welcomed Cheifetz to the company’s advisory team, noting that he looks forward to Chiefetz’s contributions as IGC develops unique cannabis combination therapies.

Cheifetz is the Medical Director of Inova VIP 360, Northern Virginia’s Concierge Medicine Program. He is also Regional Dean at Virginia Commonwealth University Inova Fairfax Campus.

He received his M.D. from the State University of New York at Buffalo and also attended Georgetown University, where he trained in internal medicine. He was National GRMC Chairman from 2011 to 2013.

“We remain committed to accelerating our initiatives and building robust a portfolio of compounds to address large market conditions,” Mukunda noted in the release.

The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for indications including depression, Alzheimer’s and Parkinson’s disease. Its lead candidate is IGC-501, and it has filed patents for the candidate in the United States, Canada and Europe.

For more information, visit the company’s website at www.IGCinc.us

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Conflicts of Interest and the Public Trust

Umpires and referees are hired to impartially officiate their respective games, enforce the rules and ensure fair play. The credence of these officials builds public trust and protects the integrity of the games. Everyone complains that the ump or the ref got the call wrong, but seldom, if ever, does anyone suspect a conflict of interest or believe these officials received payments from players, managers or owners of the teams. If these officials weren’t trustworthy, it would shake the confidence and probity of sports to its core. It would demoralize fans and destroy the games. Billions would be lost by everyone involved with sports. It’s imperative for the very life of the games that these officials maintain honesty and integrity and avoid even the appearance of conflicts of interest. Appearances matter.

If appearances do matter, why then are officials nominated and confirmed to officiate a $23 trillion game? Jay Clayton, a longtime partner at the law firm Sullivan & Cromwell, is the latest nominee to lead the Securities and Exchange Commission. Clayton follows many other SEC heads with multiple intertwined conflicts of interest that bring impartiality into question in regulating Wall Street. Clayton has represented big banks like Goldman Sachs and Barclays as well as prominent hedge funds, corporate executives and numerous companies facing intense government scrutiny. Clayton’s numerous conflicts of interest, intertwined investments and problematic clients were recently chronicled in the New York Times article, Trump’s S.E.C. Nominee Disclosure Offers Rare Glimpse of Clients and Conflicts (http://dtn.fm/t1eD7).

There is no doubt that Clayton is highly experienced and possesses an expansive understanding of market machinations. His knowledge and experience are necessary to rise to the task of running a complex government agency that regulates a complex business that utilizes complex instruments. From inception the SEC has had leadership conflicts of interest.

In 1934, Franklin Roosevelt appointed Joseph Kennedy to head the newly created Securities and Exchange Commission. FDR viewed the SEC as a part of the national recovery from the Great Depression and believed Kennedy was an ideal candidate to rein in all those other Wall Street charlatans. Through experience, Kennedy knew all the fraudulent, questionable backroom ways of lining the pockets of finance’s fat cats, and many believed the fox had been appointed chairman of the hen house. During his two years as SEC chairman, Kennedy stopped many dishonest activities and closed as many loopholes as he could, but his real mission was to make corporations feel good again about doing business. Corporations didn’t trust FDR and the New Deal, but Joe Kennedy was one of them.

Just maybe the game is rigged to promote business. The stated mission of the SEC is to protect investors; maintain fair, orderly, and efficient markets; and facilitate capital formation. The SEC also states that it strives to promote a market environment that is worthy of the public’s trust. With the current and historic appointments made to the SEC and the glaring history of conflicts of interest, it’s obvious that the SEC isn’t promoting an environment worthy of the public’s trust. The SEC is promoting an environment worthy of only the corporations’ trust.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Aims for Strike at Sully Project Amid Global Zinc Shortage

It is a prime time to be in the zinc mining business, and Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is poised to profit in the midst of a continuing global zinc shortage and simultaneously booming prices.

As recently reported (http://dtn.fm/7RcNS), the price of zinc rose to $1.17 per pound and $2,628 per metric ton as of May 2017, representing a 60 percent increase over the previous year’s prices. This exceeded already propitious predictions that a deeper worldwide shortage would send zinc prices soaring as high as $2,500 per metric ton over the course of 2017 (http://dtn.fm/Mgwq5).

The current imbalance in the global zinc market is partly attributed to the 2016 shutdown of a number of zinc mines in China — the world’s largest producer of zinc, as well as its biggest consumer. Major zinc mines in other parts of the world have been experiencing declining ore supplies, as well, which is further credited as contributing to the shortage.

Seeking to cash in on the current global zinc shortage and price hike and to help meet the growing demand, KTNNF recently reported that it is expanding its active search for zinc at its Sully Project, which is located in British Columbia, Canada, just 18 miles (30 kilometers) from the legendary Sullivan Mine. The company recently reported it has completed three exploration holes at the site and that its project team is extending its survey efforts to the property’s west anomaly, including conducting state-of-the-art gravity mapping.

The Sully Project boasts shared geologic features with the famed Sullivan Mine, and the sedimentary rocks that host the Sullivan Mine are present at Sully, representative of different environments of the same basin. So far, geologic data indicates that the Sully Project shares the same stratigraphic level at which the Sullivan Mine was deposited, and it appears to coincide with the East gravity anomaly at the Sully Project. A subtle lead-zinc soil anomaly could reflect leakage up faults and dispersion through thick till and alluvium from an entirely buried deposit. A Cominco airborne geophysical survey has shown two N-S trending magnetic anomalies underground that are up to almost two miles long (1.86), that are approximately 0.62 miles apart, and that are near-coincident with the gravity anomalies.

So far, drilling efforts at the Sully Project have been a very near miss, meaning a strike may not be far away. Initial surveying at the project indicated that drilling conducted in 2004 only narrowly missed a shallow mass there. Work performed since then indicated the target was deep. The target may have been missed by just 100 meters, according to downhole temperature and magnetic field readings taken in 2014. KTNNF has initiated a drilling program and is targeting this East mass, which has been confirmed and better defined by new gravity data.

For more information, visit the company’s website at www.KootenayZinc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BioCorRx, Inc. (BICX) Targeting Alcohol and Opioid Addiction with Innovative Two-Pronged Approach

BioCorRx (OTCQB: BICX) is the owner and creator of an innovative addiction treatment program used by a network of independent treatment centers to improve the lives of their patients struggling with alcohol and opioid addictions. The BioCorRx® Recovery Program leverages an innovative, two-pronged approach that addresses the underlying physical and behavioral issues associated with these addictions. The first half of this approach relies on a highly effective, proprietary implant formulation of the FDA-approved medication naltrexone, for which BioCorRx holds worldwide license rights (excluding Australia and New Zealand). The second half focuses on a modular counseling program coupled with overlapping peer support that is tailored specifically for those afflicted with alcohol and opioid addictions, helping to prepare them both physically and mentally for a life without these often dangerous substances.

America’s opioid epidemic is an increasingly treacherous issue that affects millions of people across the country. Per data from the Centers for Disease Control and Prevention, more than half a million people in the United States died from drug overdose from 2000 to 2015. Of those, more than 60 percent were linked to an opioid. Likewise, deaths from prescription opioids have more than quadrupled since 1999, driven by a nearly identical spike in the amount of prescription opioids sold. The negative implications associated with this addiction include traumatic life events for the addicted and their loved ones, as well as monumental financial expense. A 2010 study conducted by the American Society of Addiction Medicine found that addiction costs an estimated $700 billion annually in the U.S. alone.

Treating this growing problem has proven difficult. In 2011, the Substance Abuse and Mental Health Services Administration reported that 23.5 million persons aged 12 or older, roughly 9.3 percent of the population, needed treatment for an illicit drug or alcohol abuse problem. Of those, only 11.2 percent received the vital treatment at a specialty facility. BioCorRx aims to close this gap by both operating specialty facilities to aid those in need and providing a more thorough treatment program that’s been shown to lower patient drop-out rates, due to reduced cravings, and increase compliance rates, through automatic medication delivery and discreet outpatient treatment options.

In recent months, BioCorRx, through its BioCorRx Pharmaceuticals subsidiary, has looked to continue building on this proven medication through the clinical development of BICX101, a sustained release, injectable naltrexone for the treatment of opioid and alcohol use disorders. In early April, the company announced that three different formulations of the drug candidate showed success in reaching 28 days of sustained release in its preclinical studies, including one with an injection volume of just one milliliter. Following this result, BioCorRx formally requested a pre-IND meeting with the U.S. Food and Drug Administration as it continues to conduct additional studies in order to compile more data points.

In a business update issued earlier this month, Lourdes Felix, CFO, COO and director of BioCorRx, noted the strength of the company’s balance sheet following a March equity financing of $940,000 with accredited investors, as well as an investment of $1.7 million from Alpine Creek Capital Partners. Capital stemming from these transactions is expected to allow BioCorRx to continue executing on its business plan, including completion of “a few rounds of preclinical studies of BICX101” and accelerated sales and marketing activities related to its BioCorRx Recovery Program.

A strong balance sheet isn’t the only aspect of BioCorRx’s growth strategy about which prospective shareholders should be particularly optimistic. On May 16, the company announced its submission of a listing application for the Nasdaq Capital markets. The move comes less than two months after OTC Markets Group (OTCQX: OTCM) welcomed BioCorRx to the OTCQB Venture Market, which it reserves for early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process. The company will be required to meet a number of Nasdaq listing requirements in order to complete the uplist, but CFO Felix noted that members of BioCorRx’s management team “look forward to the prospect of a NASDAQ listing,” which they anticipate will “enhance BioCorRx’s visibility in the investment community to a larger market and provide for a broader, more diverse base of shareholders.”

Addressing the growing opioid epidemic in the United States, as well as lingering alcohol addiction issues, represents both an urgent call to action and a sizable market opportunity for companies offering proven effective treatment options. BioCorRx, through its innovative non-addictive medication-assisted treatment (MAT) program and promising clinical pipeline, represents an opportunity for the investment community to participate in the resolution of this crisis while capitalizing on the growth prospects of a leading edge health care solutions company.

For more information, visit www.BioCorRx.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Completes Acquisition of Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced the completion of its acquisition of Discount Indoor Garden Supply (“DIGS”). Under the terms of the agreement, SinglePoint has acquired a 90 percent stake in DIGS through a stock and cash transaction, further demonstrating the company’s ability to strategically expand its portfolio of investments in established, high-potential cannabis businesses. “This acquisition is an important one for SinglePoint and strengthens our footing in the cannabis industry,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “The acquisition of DIGS is phenomenal for the company’s books. More importantly though are the people that come along with this. We are investing in people we believe in, people that we know can continue to run and grow their company.” DIGS currently operates both an online store and two store front locations, with plans to open a third in the near future. Both of its stores are strategically located to capitalize on a sizable presence of licensed cannabis growers, which could provide an opportunity for considerable market growth following California’s anticipated 2018 legalization of recreational cannabis use.

To view the full press release, visit http://dtn.fm/56LRe

About SinglePoint, Inc.

SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. For more information visit www.SinglePoint.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Featured in Exclusive Audio Interview by NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire (“NNW”) this morning announced the online availability of an exclusive audio interview with mineral exploration and development company Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF). In the interview, Stuart (Tookie) Angus, an independent business advisor to the mining industry and member of Kootenay Zinc’s advisory board, offers listeners a run-down of the company’s current operations. Kootenay Zinc is currently focused on the discovery of zinc ore at its mineral property located near the famous Sullivan Mine, which was previously one of the world’s largest zinc/lead/silver deposits, producing over $49 billion worth of metal. “We are about 30 kilometers, or 18 miles, from the mine, with a current drill program underway to try and discover [an extension] for the Sullivan Mine deposit,” Angus noted in the NNW interview. “We have a number of different anomalies that we’re going to test. The truth serum in this business is the drill bit. We’re going to go in there and bravely drill to see if we can find what we hope is there.” The full interview can be head at http://dtn.fm/6q26H.

To view the full press release, visit http://dtn.fm/M9gbD

About Kootenay Zinc Corp.

Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information, visit http://www.kootenayzinc.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – CD International Enterprises, Inc. (CDII) Enters Full Corporate Offer to Purchase 1.2 Million Tons of Bauxite

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a full corporate offer with a Dominican Republic-based company for the monthly purchase of 100,000 tons of metallurgical-grade bauxite. Per the terms of the offer, CDII will be required to purchase 100,000 metric tons of bauxite per month for an initial period of 12 months, equating to a total shipment of 1.2 million metric tons. This contract is valued at approximately $37 million based on current FOB prices at Cabo Rojo, Dominican Republic. “We are pleased to enter into this agreement on the heels of signing a separate offer to purchase copper cathodes, valued at approximately $330 million,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “As part of sourcing a variety of industrial commodities for our clients in China, we are advancing our newly established business model and leveraging our existing connections in China. Upon a successful delivery of bauxite to our clients in China, we believe we will enter a new level of business.”

To view the full press release, visit http://dtn.fm/GqlK3

About CD International Enterprises, Inc.

CD International Enterprises, Inc. (OTC: CDII) is a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services. The breadth of its services allows the Company to be a one-stop shop for international companies looking to take advantage of global market opportunities. For more information about CD International, please visit http://www.cdii.net.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Launch of ‘OptHemp’ Premium Hemp Health Product Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary Chinesehempoil.com Inc., this morning announced plans to launch its own premium hemp health product line, ‘OptHemp’, as well as its first private label product, OptHemp Ultra Premium Hemp Oil. “We believe that the desire for better quality of life in the Chinese community, coupled with fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Warren Wang, founder and CEO of CIIX, stated in the news release. “CIIX is confident that its OptHemp product line will lay a solid foundation for the Company’s entrance into the legal hemp industry and the alternative health sector.” When available, the company’s OptHemp products will be sold through www.ChineseHempOil.com, CIIX’s official bi-lingual site. The products will also be available through the company’s first retail store, which is currently under construction in San Gabriel, California, with a tentative opening date set for June.

To view the full press release, visit http://dtn.fm/Uq5oV

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

CD International Enterprises (CDII) Expands Reach to 2 Billion+ via the Web

A specialist in the industrial commodities and corporate consulting services sector, CD International Enterprises, Inc. (OTC: CDII) now has access to a global market representing more than two billion prospective customers. The company has been expanding into the cannabidiol (CBD) market and recently launched a wholly-owned subsidiary and online store. Targeting Chinese-speaking communities in the U.S. and around the world, it has also been reaching into the mobile web with the ongoing development of an app to distribute CBD products through mobile devices.

The company launched its online store (http://greencbdproducts.com/cbd) this year, as well as its Green Products Distribution, Inc. subsidiary. These initiatives represent a major component of CD International’s expansion plans. As the online store reaches full functionality, products will be added to the catalog, where a secure online ordering system will enable customers to purchase the highest quality CBD oil and other products.

A contract with an online marketing firm is expected to help expand the reach of the store and its product line. On the sourcing front, the company is planning several distribution agreements with U.S. firms, in addition to its plans to work with pharmaceutical and Chinese Medicine retailers in China. Also, a recent agreement signed with GWR Distributors now means access to wholesale-priced CBD capsules, concentrates, edibles, oils, syrups, and more. This boosts the potential of the online store now in development.

The store will sell over 200 different flavored CBD hemp oils. Vape additives will be available as well. Not psychoactive like tetrahydrocannabinol (THC), CBD has been shown to benefit people with numerous diseases. In clinical studies, it has been found to be effective as a treatment for epilepsy, anxiety, inflammation, neurodegenerative diseases, and autoimmune diseases and to be a powerful antioxidant. The products sourced in the U.S. are produced to high quality standards and are in compliance with ISO 6 clean room standards. The process used yields 99 percent pure CBD isolate.

Reaching $202 million by 2015, the global cannabidiol market represents the fastest growing segment of the marijuana industry, according to a Consilium Global Research report (http://dtn.fm/ZXh2t). It is expected to reach $2.1 billion in consumer sales by 2020. Given the fluidity of U.S. and international law related to medical marijuana, CD International continues to look for new market opportunities amongst the Chinese-speaking population in the United States and abroad. Its global experience with sourcing/selling iron ore, manganese ore, and scrap metals and providing financing and logistics services positions the company to move forward in the CBD market.

“It is an exciting time to source and market CBD-based products. Around the world, the Chinese population remains health conscious, and the health benefits of CBD oils and other products mean these high-quality commodities are in high demand. We’re proud to source our products in the U.S. and have the capacity to distribute them to anywhere in the world,” Dr. James Wang, chairman and CEO of CD International Enterprises, stated in a news release.

Learn more about the Company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com (CIIX) Growing Rapidly in a Rapidly Growing Market

Savvy investors study multiple factors to identify potential stock winners. Stock screeners scan thousands of companies for insights and data to discern uncommon opportunities. The criteria utilized in a stock screening system is obviously influenced by an individual’s investment proclivities such as high yield, value, growth or price momentum, however, most stock screening systems are typically hybrids with blended criteria reflecting individual preferences and incorporating more than one investment style. P/E ratios, near zero beta, increased dividends, revenue growth and market growth are all employed to sift through over 100,000 public companies around the world and the nearly 6,000 U.S. listed companies.

All markets are addicted to growth. Growth is the elixir that drives markets and share prices of individual companies higher, and every stock screening system includes growth measurement variables. Growth is a testament to value creation. Current and future growth are prime indicators of potential future performance of a company’s share price. When looking for growth, it makes sense to look closely at companies that are not only growing rapidly but also growing rapidly in a rapidly growing market. With compound annual growth estimated at nearly 60 percent, the CBD (cannabidiol) industry is arguably the fastest growing market in the world. In fact, just five months ago Forbes called the CBD industry, “The Cannabis Market That Could Grow 700% by 2020” (http://dtn.fm/5vDve). That kind of growth can change a portfolio.

Currently legal in 16 states with more expected to follow, CBD oil is non-psychoactive and considered to have a broad range of medical benefits. Derived from hemp or marijuana plants, CBD has shown varying degrees of efficacy in treating epilepsy, Alzheimer’s disease, cirrhosis, pain, anxiety and stress.

CBD is obviously an explosive market opportunity. However, an even greater market opportunity lies outside the U.S., with over two billion Chinese speaking people. Acceptance and use of CBD oil is a natural fit with holistic Eastern-based medicine and an immense potential revenue generator for ChineseInvestors.com (OTCQB: CIIX). With two billion Chinese speaking people as its target market, ChineseInvestors.com recently executed a first-to-market milestone by creating the world’s only Chinese language, cannabinoid-based, therapeutic health products online store, www.ChineseCBDoil.com.

Historically, this specialized investment services company with 100,000+ users provided real-time market commentary, analysis, and education-related information in the Chinese language, as well as offered consultation, advertising, and public relations services. Now, the 18-year-old company is at the forefront of marketing and selling hemp-based food and beverages and hemp-derived CBD to Chinese-speaking consumers worldwide through its online store.

A recent research report by Consilium Global Research (http://dtn.fm/SA4bH) projects ChineseInvestors.com to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. Consilium sees CIIX going through immense transformation this year as it pursues a larger stake in the global cannabis market. Before long, ChineseInvestors.com should pop up on multiple stock screeners, as it’s growing rapidly in a rapidly growing market.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ProBility Media Corp. (PBYA) Enters Letter of Intent to Acquire W Marketing, Inc.

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced its entry into a binding letter of intent to acquire W Marketing, Inc., a profitable, revenue-generating provider of National Electrical Codes (NECs) to the electrical and construction industries. Leveraging W Marketing’s nationwide network of electrical distributors, which includes bookstores, trade/vocational schools, universities, retail chains, specialty retailers and independent hardware stores, ProBility expects this acquisition to strengthen its financial position while allowing it to become one of the nation’s largest wholesalers of National Fire Protection Association (NFPA) electrical codes. “We are pleased to announce this corporate milestone and look forward to demonstrating the short- and near-term value it creates,” Noah Davis, president and chief operating officer of ProBility, stated in the news release. “When the acquisition is complete, ProBility’s buying power will surpass any wholesaler on the market, and open the doors to thousands of electricians who could benefit from our certification courses, continuing education and code books. Additionally, we expect this acquisition of W Marketing will have a positive impact on forward-looking financials.” W Marketing recorded revenues of $2.7 million in fiscal 2017 following the release of the latest update to the NEC.

To view the full press release, visit http://dtn.fm/j8hAJ

About ProBility Media Corp.

ProBility Media Corp. is an EdTech company building the first full-service training and career advancement brand for the skilled trades. Through its divisions Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, One Exam Prep, LLC, and its partnership with Globalsim Inc., ProBility is executing a disruptive strategy of defragmenting the skilled trades training market place by offering high quality training courses and materials and preparing the workforce for excellence. ProBility services customers from the tradesman to the small business to the enterprise level corporation. For more information, visit http://www.ProBilityMedia.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

India Globalization Capital, Inc. (NYSE: IGC) Developing Phytocannabinoid-Based Product Pipeline to Treat Two- and Four-Legged Alike

Looking to gain an advantageous foothold in the burgeoning medical marijuana market, India Globalization Capital, Inc. (NYSE MKT: IGC) is developing innovative cannabis-based combination therapies that have application for both humans and animals. The company’s focus is on treating pain, post-traumatic stress disorder (PTSD), chronic and terminal neurological and oncological diagnoses, cachexia, and other life-altering medical conditions.

IGC continues developing a portfolio of patent filings for phytocannabinoid-based treatments and has filed six patents to date. The company currently has three products in pre-clinical trials: IGC-501 for treatment of neuropathic pain in adult humans, IGC-502 for treatment of seizures in animals, and IGC-504 for treatment of cachexia in humans and animals.

Two of IGC’s patent filings, IGC-502 and IGC-505, are for combination therapies to treat seizures in dogs and cats, which represents a remarkably large market. Statistics show that between one percent and over five percent of dogs in the United States have some kind of seizure disorder. Certain dog breeds with hereditary epilepsy may have up to 15-20 percent incidence of seizures.

IGC’s novel therapy uses cannabinoid extracts in combination with other drugs to treat seizures in both dogs and cats, and this therapy has potential for application in humans, as well. The therapy can be administered through a variety of delivery technologies.

Operating on the belief that expanding cannabis legalization will create explosive demand for cannabinoid-based pharmaceutical therapies and related technologies and services, IGC is racing to be at the head of the pack and to be a first mover in the marijuana space by developing novel therapies, filing patent applications, and acquiring technologies from related industries that can cross over to cannabis as soon as permitted by federal law.

The company largely employs an outsourced model and has formed strategic alliances with doctors and scientists with expertise in central and peripheral nervous system disorders, the FDA process, and in pharmaceutical, nutraceutical and veterinarian trials. IGC also continues seeking information exchanges with medical cannabis dispensaries, doctors, research scientists, biotech companies, and medical and business professionals within the cannabinoid space, placing great value on collaborative research that can aid in the commercialization of products and in locating new ways to help patients — both human and animal — benefit from cannabinoids.

For more information, visit the company’s website at www.IGCinc.us

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

India Globalization Capital, Inc. (NYSE: IGC) is Blazing a Trail with its Cannabis Plus Therapies

Slowly but surely cannabis is losing the stigma that has plagued it for close to one hundred years. Even some who frown on its use for recreational purposes are willing to consider that there may be therapeutic benefits in extracts of the cannabis sativa plant and so, increasingly, cannabinoids are being investigated to determine their effectiveness to treat a variety of debilitating medical conditions. Cannabinoid pharma is emerging as an entirely new industry segment in pharmaceuticals, and, as it does so, one innovative research company is blazing a trail in this new market by creating a niche of its own. India Globalization Capital, Inc. (NYSE MKT: IGC) has created its own space in pharmaceuticals. The Bethesda, Maryland-based company is a first mover in “combination therapies” that merge cannabinoids with existing drugs to provide more effective remedies.

IGC is not only a first mover in combination therapies; the company is also a fast mover. To date, IGC has dispatched six provisional patent filings to the U.S. Patent and Trademark Office for the indications of pain, medical refractory epilepsy, seizures, cachexia and eating disorders. Together, the remedies for these conditions present huge market opportunity, and IGC’s current low valuation versus comparable cannabis companies represents an important alert for all investors in this burgeoning industry.

IGC-501 is being developed to combat pain. The pain market represents a significant component of the health care system, with The Journal of Pain reporting in September 2012 that the annual estimated national cost of pain ranges from $560 billion to $635 billion, a figure that exceeds the cost of treating all other priority health conditions. Also, a NetworkNewsWire report on data released by Transparency Market Research estimates the global pain management therapeutics market will have a 3.7 percent CAGR through 2024, to reach $83.0 billion (http://dtn.fm/cMh1z).

Chronic pain takes such an exacting toll on the nation’s health that the American Pain Society has recommended pain be characterized as a fifth ‘vital sign’, along with body temperature, pulse rate, respiratory rate and blood pressure. Pain treatment can save lives. Terminal illnesses are often accompanied by levels of pain so intense and difficult to treat that death seems preferable. In addition, arthritis has been particularly problematic for women, according to the Arthritis Foundation, which reports that since 1999 there has been a 22 percent increase in the number of women who attribute their disability to arthritis.

As awareness of the effects of chronic pain has grown, increasingly powerful drugs such as morphine, codeine, and hydrocodone are being prescribed. However, these opioids are treacherously addictive and their use is often subverted from pain relief, making their way into recreational use. According to the Centers for Disease Control (CDC), 29,000 Americans die every year from opioid-related overdoses. This alarming statistic shows the pressing need for less addictive analgesics like IGC-501.

IGC-503 tackles refractory epilepsy, which affects about 50 million in the U.S. alone. Refractory epilepsy refers to cases of epilepsy that are unresponsive to current medications. Also in the pipeline is IGC-504, intended for those who suffer from cachexia, known as wasting syndrome. About 1.3 million in the U.S. experience cachexia associated with cancer, multiple sclerosis (MS), Parkinson’s, HIV/AIDS and other devastating maladies. In addition, there is IGC-506, designed to combat eating disorders, which are said to affect about 30 million Americans (http://dtn.fm/2j6Pq). Two other patents, IGC-502 and IGC-505, are designed to treat epileptic seizures in dogs and cats.

On the release of its financial results for the third-quarter ended December 31, 2016, CEO Ram Mukunda stated, “In 2017, our goal is to accelerate the development of our cannabis-based therapy portfolio to support key indications such as pain, seizures, cachexia, PTSD, and depression. In tandem, we expect to initiate pre-clinical trials on IGC-501-pain, IGC-502-seizures and IGC-504-cachexia.”

For more information, visit the company’s website at www.IGCinc.us

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Bitcoin Value Soars Despite SEC Rejecting ETF Bid, China Eyeing Trading Regulations

One of the most popular cryptocurrencies on the market, Bitcoin is reaching all-time highs on Asian trading platforms, despite recent challenges. The virtual currency has been rising in value, by 140 percent in 2016 and by roughly 50 percent in the past month alone, trading at over $1,800 on the Chinese market last week (http://dtn.fm/px7Ki). The value has dropped to around $1,700 in the meantime, but the cryptocurrency is expected to continue its growth, even if China is enforcing a series of Bitcoin trading regulations and Japan is considering the same.

One of the biggest challenges the digital currency is facing has to do with getting approval to be tied to an exchange-traded fund in the United States. Earlier this year, the U.S. Securities and Exchange Commission rejected a proposal to create a Bitcoin ETF on account of the lack of clear regulations on the markets where the cryptocurrency is traded (http://dtn.fm/EV7a8). The SEC said the lack of clear regulation on these markets raises concerns about potential manipulative or fraudulent practices in this market.

The application had been submitted by brothers Tyler and Cameron Winklevoss, who have been working on a proposed Bitcoin ETF for four years and have already won New York authorities’ regulatory approval for their virtual currency trading platform, Gemini Exchange. Other companies have also submitted approval request for Bitcoin ETFs to the SEC, and the commission may reach a different decision on those proposals, but approval is unlikely in the near future until more mature markets emerge.

Supporters of the digital currency had hoped that an ETF would help bring Bitcoin into the mainstream and make it available to retail investors via brokerage firms. The regulatory questions surrounding the currency have already deterred many financial institutions from investing significantly into Bitcoin, opting instead to focus on the underlying technology known as blockchain – a revolutionary concept that introduces a new way of processing financial transactions and keeping track of information.

Regulatory concerns over the cryptocurrency also exist on the Asian markets where Bitcoin is traded. China, responsible for almost 90 percent of all Bitcoin exchange trading, is imposing trading fees and controls, aimed at ensuring that bitcoin trading platforms are not becoming money laundering sites. A ban on cryptocurrency exchange withdrawals has also been enforced, and the country is also considering regulations that will require Bitcoin traders to register with their real names. The digital currency is being widely used by Chinese investors as a way of circumventing the country’s strict capital controls and minimizing the risk of significant losses caused by yuan deflation.

Japan, meanwhile, is taking rapid steps toward fully legitimizing the cryptocurrency, by announcing plans to allow interest-paying deposits for Bitcoin. The country has already declared Bitcoin a legal currency, establishing a platform for large corporations and institutional investors to participate in the local digital currency industry.

According to Sandeep Goenka, co-founder of one of India’s leading Bitcoin exchanges Zebpay, news of trading regulations on the two Asian markets and in Russia are partly what is driving the currency’s growth, Cointelegraph reports (http://dtn.fm/XO23d). Goenka believes that the stable growth rate is due to a global increase in awareness toward Bitcoin, as well as a growing demand from institutional investors. Instead of having a dampening effect, trading regulations will only help bring the cryptocurrency into the mainstream, says the Zebpay co-founder. In his opinion, the price of Bitcoin could reach $3,500 by the end of the year.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net